Notice Concerning Changes in Directors
Filed with TSE · · 1 page · English
August 3, 2026 Company name: COSMOS Pharmaceutical Corporation Name of representative: Hideaki Yokoyama, President Contact: Motoi Takemori, Corporate Planning Department Manager (Phone: +81-92-433-0660) Notice Concerning Changes in Directors COSMOS Pharmaceutical Corporation (the “Company”) hereby notifies that, at a meeting of the Board of Directors held today, it determined to nominate candidate
COSMOS Pharmaceutical Corporation on 6ix
Earlier from COSMOS Pharmaceutical
- Consolidated Financial Results for the Fiscal Year Ended May 31, 2026[Japanese GAAP]
- COSMOS Pharmaceutical: Consolidated Financial Results for the Fiscal Year Ended May 31, 2022
Later from COSMOS Pharmaceutical
- View and Policy on Reduction of Investment Unit
- Consolidated Financial Results for the Three Months Ended August 31, 2026(Under Japanese GAAP)
Follow COSMOS Pharmaceutical into a list and get an email when it puts out news.
Follow COSMOS Pharmaceutical